Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08NJE
|
||||
Former ID |
DIB011286
|
||||
Drug Name |
CR-845 iv infusion
|
||||
Synonyms |
CR-845; Kappa opioid agonist (intravenous, pain), Cara/Ferring; Kappa opioid agonist (oral, pain), Cara/Ferring; Kappa opioid agonist (subcutaneous, pain), Cara/Ferring; CR-845 (iv infusion, pain), Cara/Ferring; CR-845 (oral capsule, pain), Cara/Ferring; CR-845 (subcutaneous, pain), Cara/Ferring; FE-202845 (iv, pain), Cara/Ferring; FE-202845 (oral, pain), Cara/Ferring; FE-202845 (sc, pain), Cara/Ferring
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 2/3 | [525310] | ||
Company |
Cara Therapeutics Inc; cara therapeutics
|
||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Agonist | [544079] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.